Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Liver X receptors regulate cholesterol homeostasis in oligodendrocytes.

Nelissen K, Mulder M, Smets I, Timmermans S, Smeets K, Ameloot M, Hendriks JJ.

J Neurosci Res. 2012 Jan;90(1):60-71. doi: 10.1002/jnr.22743. Epub 2011 Oct 3.

PMID:
21972082
2.

Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.

Kappus MS, Murphy AJ, Abramowicz S, Ntonga V, Welch CL, Tall AR, Westerterp M.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):279-84. doi: 10.1161/ATVBAHA.113.302781. Epub 2013 Dec 5.

3.

Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.

Ramírez CM, Rotllan N, Vlassov AV, Dávalos A, Li M, Goedeke L, Aranda JF, Cirera-Salinas D, Araldi E, Salerno A, Wanschel A, Zavadil J, Castrillo A, Kim J, Suárez Y, Fernández-Hernando C.

Circ Res. 2013 Jun 7;112(12):1592-601. doi: 10.1161/CIRCRESAHA.112.300626. Epub 2013 Mar 21.

4.

Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.

Taylor JM, Borthwick F, Bartholomew C, Graham A.

Cardiovasc Res. 2010 Jun 1;86(3):526-34. doi: 10.1093/cvr/cvq015. Epub 2010 Jan 18.

PMID:
20083572
5.

Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.

Yan W, Zhang T, Cheng J, Zhou X, Qu X, Hu H.

Pharmacology. 2010;86(5-6):306-12. doi: 10.1159/000321320. Epub 2010 Nov 10.

PMID:
21071998
6.

Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.

Honzumi S, Shima A, Hiroshima A, Koieyama T, Terasaka N.

Biochim Biophys Acta. 2011 Dec;1811(12):1136-45. doi: 10.1016/j.bbalip.2011.08.009. Epub 2011 Aug 19.

PMID:
21875689
7.

Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.

Meffre D, Shackleford G, Hichor M, Gorgievski V, Tzavara ET, Trousson A, Ghoumari AM, Deboux C, Nait Oumesmar B, Liere P, Schumacher M, Baulieu EE, Charbonnier F, Grenier J, Massaad C.

Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7587-92. doi: 10.1073/pnas.1424951112. Epub 2015 May 28.

8.

Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.

Ku CS, Park Y, Coleman SL, Lee J.

J Nutr Biochem. 2012 Oct;23(10):1271-6. doi: 10.1016/j.jnutbio.2011.07.007. Epub 2011 Dec 29.

PMID:
22209005
9.

LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.

Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T.

J Lipid Res. 2009 Feb;50(2):301-11. doi: 10.1194/jlr.M800374-JLR200. Epub 2008 Aug 30.

10.

The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia?

Plösch T, Gellhaus A, van Straten EM, Wolf N, Huijkman NC, Schmidt M, Dunk CE, Kuipers F, Winterhager E.

Placenta. 2010 Oct;31(10):910-8. doi: 10.1016/j.placenta.2010.07.009. Epub 2010 Aug 14.

PMID:
20709391
11.

LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.

Murthy S, Born E, Mathur SN, Field FJ.

J Lipid Res. 2002 Jul;43(7):1054-64.

12.

Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.

Shridas P, Bailey WM, Gizard F, Oslund RC, Gelb MH, Bruemmer D, Webb NR.

Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):2014-21. doi: 10.1161/ATVBAHA.110.210237.

13.

Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.

Norata GD, Ongari M, Uboldi P, Pellegatta F, Catapano AL.

Int J Mol Med. 2005 Oct;16(4):717-22.

PMID:
16142410
14.

Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.

Ulven SM, Dalen KT, Gustafsson JA, Nebb HI.

J Lipid Res. 2004 Nov;45(11):2052-62. Epub 2004 Aug 1.

15.

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.

Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P.

Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):507-12. Epub 2001 Jan 9.

16.

Phospholipase A(2)-modified low-density lipoprotein activates liver X receptor in human macrophages.

Morbitzer D, Namgaladze D, Brüne B.

Cell Biochem Biophys. 2012 Jun;63(2):143-9. doi: 10.1007/s12013-012-9351-4.

PMID:
22367754
17.

The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.

Dai XY, Ou X, Hao XR, Cao DL, Tang YL, Hu YW, Li XX, Tang CK.

J Cardiovasc Pharmacol. 2008 May;51(5):467-75. doi: 10.1097/FJC.0b013e31816a5be3.

PMID:
18437096
18.

Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.

Jasmin SB, Pearson V, Lalonde D, Domenger D, Théroux L, Poirier J.

Brain Res. 2014 May 8;1562:39-51. doi: 10.1016/j.brainres.2014.03.016. Epub 2014 Mar 21.

19.

Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.

Grefhorst A, Oosterveer MH, Brufau G, Boesjes M, Kuipers F, Groen AK.

Atherosclerosis. 2012 Jun;222(2):382-9. doi: 10.1016/j.atherosclerosis.2012.02.014. Epub 2012 Mar 3.

20.

Phospholipid transfer protein is regulated by liver X receptors in vivo.

Cao G, Beyer TP, Yang XP, Schmidt RJ, Zhang Y, Bensch WR, Kauffman RF, Gao H, Ryan TP, Liang Y, Eacho PI, Jiang XC.

J Biol Chem. 2002 Oct 18;277(42):39561-5. Epub 2002 Aug 9.

Supplemental Content

Support Center